S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Cardiff Oncology (TROV) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
benzinga.com logoCardiff Oncology Stock (NASDAQ:CRDF) Dividends: History, Yield and Dates
benzinga.com - February 23 at 8:35 AM
markets.businessinsider.com logoCardiff Oncology’s Onvansertib Shows Promise: An Analysis of the Buy Rating Recommendation
markets.businessinsider.com - September 29 at 7:51 AM
marketwatch.com logoStocks to Watch: MillerKnoll, Cardiff Oncology, Morphic Holdings
marketwatch.com - September 26 at 8:02 PM
marketwatch.com logoCardiff Oncology Shares Up 26% After Potential Cancer Treatment Advances
marketwatch.com - August 8 at 1:26 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Cardiff Oncology (CRDF)
markets.businessinsider.com - August 8 at 8:26 AM
fool.com logoCardiff Oncology (NASDAQ: CRDF)
fool.com - May 27 at 10:27 PM
forbes.com logoCardiff Oncology
forbes.com - January 13 at 4:28 PM
seekingalpha.com logoCardiff Oncology: Staying The Course
seekingalpha.com - December 14 at 9:58 AM
markets.businessinsider.com logoClear Channel Outdoor And 2 Other Penny Stocks Insiders Are Aggressively Buying
markets.businessinsider.com - October 16 at 3:13 PM
finance.yahoo.com logoCardiff Oncology, Inc. (CRDF)
finance.yahoo.com - September 29 at 6:59 PM
seekingalpha.com logoCRDF Cardiff Oncology, Inc.
seekingalpha.com - September 24 at 9:47 AM
msn.com logoLooking Into Cardiff Oncology's Return On Capital Employed
msn.com - August 25 at 1:45 AM
seekingalpha.com logoCardiff Oncology: Down But Not Out
seekingalpha.com - August 22 at 7:24 PM
finance.yahoo.com logoCardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - July 28 at 1:28 PM
stocknews.com logo5 Oncology Stocks Wall Street Predicts Will Rally 135% or More
stocknews.com - May 31 at 9:29 AM
prnewswire.com logoCardiff Oncology to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC
prnewswire.com - March 22 at 9:23 AM
prnewswire.com logoCardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates
prnewswire.com - August 5 at 4:18 PM
Get Cardiff Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for TROV and its competitors with MarketBeat's FREE daily newsletter.



TROV Media Mentions By Week

TROV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TROV
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

TROV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TROV Articles
This Week

1

0

TROV Articles
Average Week

Get Cardiff Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for TROV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TROV) was last updated on 2/29/2024 by MarketBeat.com Staff